Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (18712)
All Articles published online
|
Publishing Process of This Article
|
Jul 21, 2017 (publication date) through Jul 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | D’Aoust J, Battat R, Bessissow T. Management of inflammatory bowel disease with Clostridium difficile infection. World J Gastroenterol 2017; 23(27): 4986-5003 [PMID: 28785153 DOI: 10.3748/wjg.v23.i27.4986] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i27/4986.htm |
| Number | Citing Articles |
| 1 |
Edward V Loftus, Daniel C Baumgart, Krisztina Gecse, Jami A Kinnucan, Susan B Connelly, Leonardo Salese, Chinyu Su, Kenneth K Kwok, John C Woolcott, Alessandro Armuzzi.
Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program. Inflammatory Bowel Diseases 2023; 29(5): 744 doi: 10.1093/ibd/izac139
|
| 2 |
Puo‐Hsien Le, Chyi‐Liang Chen, Chia‐Jung Kuo, Pai‐Jui Yeh, Chien‐Chang Chen, Yi‐Ching Chen, Cheng‐Tang Chiu, Hao‐Tsai Cheng, Yung‐Kuan Tsou, Yu‐Bin Pan, Cheng‐Hsun Chiu. Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized IBD Patients and the Role of Fecal Microbiota Transplantation: A Retrospective Cohort Study. The Kaohsiung Journal of Medical Sciences 2025; 41(5) doi: 10.1002/kjm2.70002
|
| 3 |
Krista Vitikainen, Johanna Haapamäki, Martti Färkkilä, Veli-Jukka Anttila, Perttu Arkkila. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study. Scandinavian Journal of Gastroenterology 2018; 53(8): 947 doi: 10.1080/00365521.2018.1492012
|
| 4 |
C. Rodríguez, E. Romero, L. Garrido-Sanchez, G. Alcaín-Martínez, RJ. Andrade, B. Taminiau, G. Daube, E. García-Fuentes. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE. Gut Microbes 2020; 12(1): 1725220 doi: 10.1080/19490976.2020.1725220
|
| 5 |
Laura Cook, May Q Wong, William D Rees, Alana Schick, Daniel J Lisko, Genelle R Lunken, Xiaojiao Wang, Hannah Peters, Laura Oliveira, Torey Lau, Regan Mah, Brian Bressler, Megan K Levings, Theodore S Steiner. Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection. Inflammatory Bowel Diseases 2024; 30(5): 820 doi: 10.1093/ibd/izad238
|
| 6 |
Abdulaziz Saad Alshahrani, Danah Mohammad, Mohammad attieh Alzahrani, Neeraj Narula. Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study. Saudi Pharmaceutical Journal 2023; 31(9): 101736 doi: 10.1016/j.jsps.2023.101736
|
| 7 |
Máire A. Conrad, Abby L. Kaplan, Sarah Weinbrom, Silvia Nastasio, Diana Jo, Katie Conover, Kathleen Lo, Enju Liu, Melissa Crawford, Sonia Michail, Maribeth Nicholson, Suchitra K. Hourigan, Judith R. Kelsen, Stacy A. Kahn. Fidaxomicin Treatment of Clostridioides difficile Infections and Recurrences in Children and Adolescents: A Retrospective Multicenter Study. The Journal of Pediatrics 2025; 285: 114681 doi: 10.1016/j.jpeds.2025.114681
|
| 8 |
Annick Moens, Bram Verstockt, Kathleen Machiels, Peter Bossuyt, Ann Verdonck, Katrien Lagrou, Gert van Assche, Séverine Vermeire, Marc Ferrante. Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades. European Journal of Gastroenterology & Hepatology 2019; 31(6): 668 doi: 10.1097/MEG.0000000000001394
|
| 9 |
D. S. Purgina, L. V. Lyalina, V. V. Rassokhin. Clostridium diffi cile infection and its eff ect on the course of infl ammatory bowel diseases. Clinical Medicine (Russian Journal) 2022; 100(7-8): 346 doi: 10.30629/0023-2149-2022-100-7-8-346-356
|
| 10 |
Bogdan Mihnea Ciuntu, Gheorghe G. Balan, Mihaela Buna-Arvinte, Irina Mihaela Abdulan, Adelina Papancea, Ștefan Lucian Toma, Bogdan Veliceasa, Oana Viola Bădulescu, Gabriela Ghiga, Ana Maria Fătu, Mihai Bogdan Vascu, Antonia Moldovanu, Dan Vintilă, Alin Mihai Vasilescu. Clostridium difficile Infections in an Emergency Surgical Unit from North-East Romania. Medicina 2023; 59(5): 830 doi: 10.3390/medicina59050830
|
| 11 |
Lijun Dong, Jingwen Xie, Youyi Wang, Daming Zuo. Gut Microbiota and Pathogenesis of Organ Injury. Advances in Experimental Medicine and Biology 2020; 1238: 165 doi: 10.1007/978-981-15-2385-4_10
|
| 12 |
Emily R Jonica, Carol A Sulis, Kanupriya Soni, Michelle Hughes, Eric Jones, Janice Weinberg, Nancy S Miller, Francis A Farraye. Role of Cycle Threshold in Clostridioides difficile Polymerase Chain Reaction Testing as a Predictor of Clinical Outcomes in Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 2019; 1(3) doi: 10.1093/crocol/otz036
|
| 13 |
Joshua L. Hudson, Edward L. Barnes. Management of Inpatient Inflammatory Bowel Disease. 2022; : 211 doi: 10.1007/978-1-0716-1987-2_10
|
| 14 |
Lilia Davenport, Jamie Chin-Hon, Juri Chung, Xian Jie Cindy Chen, Jeffrey Schneider. 6-Mercaptopurine and Macrophage Activation Syndrome Case Report and Review of the Literature. Journal of Pharmacy Practice 2023; 36(4): 1015 doi: 10.1177/08971900221081617
|
| 15 |
Pengyu Lei, Haiyang Yu, Jiahui Ma, Jiao Du, Yimeng Fang, Qinsi Yang, Kun Zhang, Li Luo, Libo Jin, Wei Wu, Da Sun. Cell membrane nanomaterials composed of phospholipids and glycoproteins for drug delivery in inflammatory bowel disease: A review. International Journal of Biological Macromolecules 2023; 249: 126000 doi: 10.1016/j.ijbiomac.2023.126000
|
| 16 |
Abin Chandrakumar, Hussein Zohni, Wael El-Matary.
Clostridioides difficile Infection in Children With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2020; 26(11): 1700 doi: 10.1093/ibd/izz285
|
| 17 |
Panagiota Xaplanteri, Chrysanthi Oikonomopoulou, Chrysanthi Xini, Charalampos Potsios. Community-Acquired Clostridioides difficile Infection: The Fox Among the Chickens. International Journal of Molecular Sciences 2025; 26(10): 4716 doi: 10.3390/ijms26104716
|
| 18 |
Jakob Seidelin, Johan Burisch. Biomarkers in Inflammatory Bowel Diseases. 2019; : 281 doi: 10.1007/978-3-030-11446-6_23
|
| 19 |
Lizhi Zhang, Tsung-Teh Wu. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases. 2019; : 373 doi: 10.1007/978-3-030-15573-5_15
|
| 20 |
Seth R. Shaffer, Zoann Nugent, Charles N. Bernstein, Andrew Walkty, Harminder Singh. Effect of clinical versus administrative data definitions on the epidemiology of C. difficile among hospitalized individuals with IBD: a population-based cohort study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02223-y
|
| 21 |
Beatriz Gros, Pilar Soto, Manuel Causse, Sandra Marín, Eva Iglesias, Jose Manuel Benítez. Impact ofClostridioides difficileinfection in patients admitted with ulcerative colitis. Scandinavian Journal of Gastroenterology 2023; 58(3): 232 doi: 10.1080/00365521.2022.2121175
|
| 22 |
Chuan Liu, Rong Yu, Jixiang Zhang, Shuchun Wei, Fumin Xue, Yingyun Guo, Pengzhan He, Lining Shang, Weiguo Dong. Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.972079
|
| 23 |
Shreyak Sharma, Darrick K Li, Louis J Levine, Abdelkader Chaar, Chandler McMillan, Jill K J Gaidos, Deborah D Proctor, Badr Al-Bawardy. Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis. Crohn's & Colitis 360 2023; 5(3) doi: 10.1093/crocol/otad032
|
| 24 |
M. Ellen Kuenzig, Eric I. Benchimol, Charles N. Bernstein, Alain Bitton, Matthew W. Carroll, Anne M. Griffiths, Gilaad G. Kaplan, Geoffrey C. Nguyen, Anthony R. Otley, Therese A. Stukel, Trevor J.B. Dummer, Wael El‐Matary, Kevan Jacobson, Jennifer L. Jones, Lisa M. Lix, David R. Mack, Sanjay K. Murthy, Juan‐Nicolás Peña‐Sánchez, Laura E. Targownik, Stephen G. Fung, Sarah Spruin, Stephanie Coward, Yunsong Cui, Christopher Filliter, Zoann Nugent, Shabnaz Siddiq, Harminder Singh. Hospitalization With Clostridioides difficile in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2022; 75(2): 173 doi: 10.1097/MPG.0000000000003489
|
| 25 |
Mei Bai, Hong Guo, Xiao-Yao Zheng. Inflammatory bowel disease and Clostridium difficile infection: clinical presentation, diagnosis, and management. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231207280
|
| 26 |
Leslie Sangurima, Maujid Masood Malik, Nency Ganatra, Rosemary Siby, Sanjay Kumar, Sara Khan, Doju Cheriachan, Lubna Mohammed. Clostridioides difficile Infection in Inflammatory Bowel Disease Patients: A Systematic Review of Risk Factors and Approach in Management. Cureus 2023; doi: 10.7759/cureus.43134
|
| 27 |
Trusha Nana, Chanelle Moore, Tom Boyles, Adrian J. Brink, Joy Cleghorn, Lesley M. Devenish, Briette du Toit, Ernst S. Fredericks, Molebogeng R. Lekalakala-Mokaba, Caroline Maluleka, Muhammad N. Rajabally, Gary Reubenson, Liliwe Shuping, Karin Swart, Khine Swe Swe Han, Jeannette Wadula, Justyna Wojno, Warren Lowman. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. Southern African Journal of Infectious Diseases 2020; 35(1) doi: 10.4102/sajid.v35i1.219
|
| 28 |
Sara El Ouali, Jean-Paul Achkar. Management of Inpatient Inflammatory Bowel Disease. 2022; : 161 doi: 10.1007/978-1-0716-1987-2_8
|
| 29 |
Hiromu Fukuda, Shinichiro Shinzaki, Akira Doi, Shunsuke Yoshii, Teppei Yoshioka, Yoshiki Tsujii, Takahiro Inoue, Ryotaro Sakamori, Tetsuo Takehara. Concomitant <i>Clostridioides difficile</i> and<i> Edwardsiella tarda</i> Infection in a Patient with Ulcerative Colitis. Internal Medicine 2023; 62(12): 1757 doi: 10.2169/internalmedicine.0571-22
|
| 30 |
Xiaoyu Yang, Linai Kuang, Zhiping Chen, Lei Wang. Multi-Similarities Bilinear Matrix Factorization-Based Method for Predicting Human Microbe–Disease Associations. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.754425
|
| 31 |
Parisa Shoaei, Hasan Shojaei, Mohammad Jalali, Farzin Khorvash, Sayed Mohsen Hosseini, Behrooz Ataei, Bahareh Vakili, Fatemeh Ebrahimi, Hossein Tavakoli, Zahra Esfandiari, J. Scott Weese. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-3965-8
|
| 32 |
Aleksandra Tarasiuk, Guido Eibl. Nutritional Support and Probiotics as a Potential Treatment of IBD. Current Drug Targets 2020; 21(14): 1417 doi: 10.2174/1389450121666200504075519
|
| 33 |
Bhairavi Balram, Robert Battat, Alex Al-Khoury, Julie D’Aoust, Waqqas Afif, Alain Bitton, Peter L Lakatos, Talat Bessissow. Risk Factors Associated withClostridium difficileInfection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Journal of Crohn's and Colitis 2019; 13(1): 27 doi: 10.1093/ecco-jcc/jjy143
|
| 34 |
Ryan Njeim, Elie Moussa, Chapman Wei, Joelle Sleiman, Reem Dimachkie, Liliane Deeb. Impact of Biologics and Proton Pump Inhibitors on Gastrointestinal Infection Risk in Inflammatory Bowel Disease Patients: A Retrospective Analysis of Pathogen-Specific Outcomes and Treatment Interactions. Biomedicines 2025; 13(7): 1676 doi: 10.3390/biomedicines13071676
|
| 35 |
O. M. Drapkina, L. B. Lazebnik, I. G. Bakulin, M. S. Zhuravleva, N. V. Bakulina, E. V. Skazyvaeva, S. I. Sitkin, M. I. Skalinskaya, O. I. Solovyeva, E. Yu. Eremina, S. V. Tikhonov, T. S. Fil', T. L. Pilat, Yu. G. Kuznetsova, R. A. Khanferyan, M. A. Livzan, M. F. Osipenko, D. I. Abdulganieva, L. V. Tarasova, A. I. Khavkin. <i>Clostridioides difficile</i> infection: diagnosis, treatment, and prevention Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine, the Gastroenterological Scientific Society of Russia, and the North- West Society of Gastroenterologists and Hepatologists. Experimental and Clinical Gastroenterology 2023; (2): 4 doi: 10.31146/1682-8658-ecg-210-2-4-32
|
| 36 |
Angela Y. Lam, Liat S. Gutin, Yume Nguyen, Fernando S. Velayos. Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences 2020; 65(11): 3111 doi: 10.1007/s10620-020-06521-x
|
| 37 |
Mengjun Tang, Chunhua Wang, Ying Xia, Jian Tang, Jiao Wang, Liang Shen. Clostridioides difficile infection in inflammatory bowel disease: a clinical review. Expert Review of Anti-infective Therapy 2024; 22(5): 297 doi: 10.1080/14787210.2024.2347955
|
| 38 |
Xiuping Wan, Caijie Zhang, Pengyu Lei, Hanbing Wang, Rongbing Chen, Qinsi Yang, Yongwei Cheng, Wei Wu, Da Sun, Xiaofei Hong. Precision therapeutics for inflammatory bowel disease: advancing ROS-responsive nanoparticles for targeted and multifunctional drug delivery. Journal of Materials Chemistry B 2025; 13(10): 3245 doi: 10.1039/D4TB02868F
|
| 39 |
Sibel Bolukcu, IsmailNecati Hakyemez, BilgeSumbul Gultepe, Gulay Okay, Bulent Durdu, MelihaMeric Koc, Turan Aslan. Clostridium difficile infection: Is there a change in the underlying factors? Inflammatory bowel disease and Clostridium difficile. Saudi Journal of Gastroenterology 2019; 25(6): 0 doi: 10.4103/sjg.SJG_44_19
|
| 40 |
Jacob R. Sweeney, Carl V. Crawford, Rhonda K. Yantiss. Histological features of Clostridioides difficile colitis in patients with inflammatory bowel disease. Histopathology 2022; 81(3): 312 doi: 10.1111/his.14702
|
| 41 |
Qianyun Lin, Zitong Li, Lei Lu, Hua Xu, Eddie Lou, Alyssa Chen, Dustin Sun, Wuyi Zhang, Weishu Zhu, Eric U. Yee, Pamela Suzanne Sears, Xinhua Chen, Ciaran P. Kelly. Budesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice. Biomedicine & Pharmacotherapy 2023; 167: 115489 doi: 10.1016/j.biopha.2023.115489
|
| 42 |
Annu Gupta, Christopher Wash, Yingxing Wu, Dario Sorrentino, Vu Q. Nguyen. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2021; 66(2): 547 doi: 10.1007/s10620-020-06205-6
|
| 43 |
Raphael Enaud, Thierry Lamireau. Pediatric Inflammatory Bowel Disease. 2023; : 217 doi: 10.1007/978-3-031-14744-9_17
|
| 44 |
Yukito Okura, Katsumasa Kobayashi, Yurina Yamada, Makoto Furuya, Naoki Kitano, Eri Oshina, Mana Matsuoka, Takahito Nozaka, Yoshihiro Tashiro, Ayako Sato, Masato Yauchi, Taichi Matsumoto, Yohei Furumoto, Toru Asano, Seishin Azuma. A case of refractory immune checkpoint inhibitor‐induced colitis with Clostridioides difficile infection. DEN Open 2023; 3(1) doi: 10.1002/deo2.176
|
| 45 |
Le Su, Feifan Ma, Zaiyong An, Xiuyu Ji, Ping Zhang, Qiulin Yue, Chen Zhao, Xin Sun, Kunlun Li, Baojun Li, Xinli Liu, Lin Zhao. The Metabolites of Lactobacillus fermentum F-B9-1 Relieved Dextran Sulfate Sodium-Induced Experimental Ulcerative Colitis in Mice. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.865925
|
| 46 |
Najmeh Aletaha, Zohreh Dadvar, Babak Salehi, Pardis Ketabi Moghadam, Ali Niksirat, Akram Jowkar, Reza Taslimi, Seyed Farshad Allameh, Naser Ebrahimi Daryani. Clinical and Pathological Features of Ulcerative Colitis in Patients with and without Clostridium Difficile Infection; An Observational Study. Middle East Journal of Digestive Diseases 2018; 11(1): 17 doi: 10.15171/mejdd.2018.123
|
| 47 |
Siqi Wang, Wenlin Deng, Fang Li, Leyang Xiang, Pinjing Lv, Ye Chen. Treatment with butyrate alleviates dextran sulfate sodium and Clostridium difficile-induced colitis by preventing activity of Th17 cells via regulation of SIRT1/mTOR in mice. The Journal of Nutritional Biochemistry 2023; 111: 109155 doi: 10.1016/j.jnutbio.2022.109155
|
| 48 |
Kang-Moon Lee. Monitoring Disease Activity: How and When?. The Korean Journal of Gastroenterology 2018; 71(2): 69 doi: 10.4166/kjg.2018.71.2.69
|
| 49 |
Daisuke Oka, Naomitsu Yamaya, Takuya Kuno, Yuta Asakawa, Toshiyuki Shiragiku, Liang Chen, Jingbo Xue, Abudusaimi Mamuti, Fangguo Ye, Jiangqin Sun, Kinue Ohguro, Hisashi Miyamoto, Yukitaka Uematsu, Katsuya Inagaki, Jie-Fei Cheng, Makoto Matsumoto.
In Vitro
and
In Vivo
Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile
. Antimicrobial Agents and Chemotherapy 2021; 65(4) doi: 10.1128/AAC.01170-20
|
| 50 |
Raquel Linares, Rubén Francés, Ana Gutiérrez, Oriol Juanola. Bacterial Translocation as Inflammatory Driver in Crohn’s Disease. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.703310
|
| 51 |
Si Yu, Xiaomeng Ge, Hui Xu, Bei Tan, Bowen Tian, Yujie Shi, Yimin Dai, Yue Li, Songnian Hu, Jiaming Qian. Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1129043
|
| 52 |
Puo-Hsien Le, Cheng-Tang Chiu, Pai-Jui Yeh, Yu-Bin Pan, Cheng-Hsun Chiu. Clostridium innocuum infection in hospitalised patients with inflammatory bowel disease. Journal of Infection 2022; 84(3): 337 doi: 10.1016/j.jinf.2021.12.031
|
| 53 |
Pernille Dige Ovesen, Mohamed Attauabi, Johan F K F Ilvemark, Mads Damsgaard Wewer, David J Warren, Johan Burisch, Rolf A Klaasen, Nils Bolstad, Casper Steenholdt, Jakob Benedict Seidelin. Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort. BMJ Open Gastroenterology 2024; 11(1): e001343 doi: 10.1136/bmjgast-2024-001343
|
| 54 |
Isa Seida, Zeynep Betul Balcioglu, Kamyar Neyestani, Naim Mahroum. Infection and Autoimmunity. 2024; : 823 doi: 10.1016/B978-0-323-99130-8.00011-8
|
| 55 |
Xi-ya Jin, Dan-dan Li, Wei Quan, Yang Chao, Bin Zhang. Leaky gut, circulating immune complexes, arthralgia, and arthritis in IBD: coincidence or inevitability?. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1347901
|
| 56 |
Yassine Kilani, Saqr Alsakarneh, Mohammad Aldiabat, Mariana Nunes Ferreira, Daniel Alejandro Gonzalez Mosquera, Fouad Jaber, Francis A. Farraye, Jana G. Hashash. Frailty and Inflammatory Bowel Disease: A Nationwide Assessment. Gastro Hep Advances 2024; 3(7): 1001 doi: 10.1016/j.gastha.2024.07.003
|
| 57 |
Mahmoud H. Mosli, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Amr M. Khardaly, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Bawardy. Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease. Saudi Journal of Gastroenterology 2023; 29(Suppl 1): S1 doi: 10.4103/sjg.sjg_277_22
|
| 58 |
Qing Li, Xiaomei Song, Peizhu Su, Xiaoping Lv, Xinyu Liu, Xuemin Chen, Jian Tang, Xiang Gao, Kang Chao. Risk factors and clinical characteristics of Clostridium difficile colonization and infection in patients with inflammatory bowel disease exposed to Vedolizumab: a multicenter retrospective study. Therapeutic Advances in Gastroenterology 2025; 18 doi: 10.1177/17562848251321707
|
| 59 |
Xiujuan Lei, Yueyue Wang. Predicting Microbe-Disease Association by Learning Graph Representations and Rule-Based Inference on the Heterogeneous Network. Frontiers in Microbiology 2020; 11 doi: 10.3389/fmicb.2020.00579
|
| 60 |
Chloé Vuillamy, Jean-Philippe Arnault, Mathurin Fumery, Laurent Mortier, Sandrine Monestier, Sandrine Mansard, Guido Bens, Anne-Bénédicte Duval-Modeste, Elisa Funck-Brentano, Géraldine Jeudy, Laurent Machet, Guillaume Chaby, Ali Dadban, Catherine Lok. Clostridium difficile infection and immune checkpoint inhibitor–induced colitis in melanoma: 18 cases and a review of the literature. Melanoma Research 2023; 33(3): 192 doi: 10.1097/CMR.0000000000000878
|
| 61 |
Alina Boeriu, Adina Roman, Crina Fofiu, Daniela Dobru. The Current Knowledge on Clostridioides difficile Infection in Patients with Inflammatory Bowel Diseases. Pathogens 2022; 11(7): 819 doi: 10.3390/pathogens11070819
|
| 62 |
Hiromu Morikubo, Takayoshi Nagahama, Katsuhiko Nagai, Hajime Yamazaki, Taku Kobayashi. Impact of Concomitant Prescriptions and Lifestyle Factors on the Initial Course of Newly Diagnosed Inflammatory Bowel Disease. Inflammatory Intestinal Diseases 2024; 9(1): 260 doi: 10.1159/000541984
|
| 63 |
Antonietta D’Errico, Deborah Malvi. Ulcerative Colitis. Updates in Surgery 2019; : 61 doi: 10.1007/978-88-470-3977-3_5
|
| 64 |
Rahul S. Dalal, Jessica R. Allegretti. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease. Current Opinion in Gastroenterology 2021; 37(4): 336 doi: 10.1097/MOG.0000000000000739
|